Department of Radiology and Cardiology, Center for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, 1081 Burrard Street, Vancouver V6Z1Y6, BC, Canada.
Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands.
Eur Heart J. 2021 May 14;42(19):1912-1925. doi: 10.1093/eurheartj/ehaa768.
Our understanding of the complexities of valvular heart disease (VHD) has evolved in recent years, primarily because of the increased use of multimodality imaging (MMI). Whilst echocardiography remains the primary imaging technique, the contemporary evaluation of patients with VHD requires comprehensive analysis of the mechanism of valvular dysfunction, accurate quantification of severity, and active exclusion extravalvular consequences. Furthermore, advances in surgical and percutaneous therapies have driven the need for meticulous multimodality imaging to aid in patient and procedural selection. Fundamental decision-making regarding whom, when, and how to treat patients with VHD has become more complex. There has been rapid technological advancement in MMI; many techniques are now available in routine clinical practice, and their integration into has the potential to truly individualize management strategies. This review provides an overview of the current evidence for the use of MMI in VHD, and how various techniques within each modality can be used practically to answer clinical conundrums.
近年来,我们对瓣膜性心脏病(VHD)复杂性的理解已经发展,主要是因为多模态成像(MMI)的使用增加。虽然超声心动图仍然是主要的成像技术,但当代 VHD 患者的评估需要对瓣膜功能障碍的机制进行全面分析,准确量化严重程度,并积极排除瓣外后果。此外,手术和经皮治疗的进步推动了对精细多模态成像的需求,以帮助患者和程序选择。关于谁、何时以及如何治疗 VHD 患者的基本决策变得更加复杂。MMI 技术发展迅速;许多技术现在已在常规临床实践中使用,将其整合到临床实践中有可能真正实现个体化的管理策略。本综述提供了 MMI 在 VHD 中的应用的当前证据概述,以及每种模态中的各种技术如何实际用于解决临床难题。